Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-25 @ 8:36 PM
Study NCT ID:
NCT04317703
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2020-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.
Sponsor:
LG Chem
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-19
First Submit QC Date:
None
Study First Post Date:
2020-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-04
Last Update Post Date:
2021-02-09
Last Update Post Date Type:
ACTUAL